Literature DB >> 18594950

Gene targeting of CK2 catalytic subunits.

David C Seldin1, David Y Lou, Paul Toselli, Esther Landesman-Bollag, Isabel Dominguez.   

Abstract

Protein kinase CK2 is a highly conserved and ubiquitous serine-threonine kinase. It is a tetrameric enzyme that is made up of two regulatory CK2beta subunits and two catalytic subunits, either CK2alpha/CK2alpha, CK2alpha/CK2alpha', or CK2alpha'/CK2alpha'. Although the two catalytic subunits diverge in their C termini, their enzymatic activities are similar. To identify the specific function of the two catalytic subunits in development, we have deleted them individually from the mouse genome by homologous recombination. We have previously reported that CK2alpha' is essential for male germ cell development, and we now demonstrate that CK2alpha has an essential role in embryogenesis, as mice lacking CK2alpha die in mid-embryogenesis, with cardiac and neural tube defects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18594950      PMCID: PMC3696998          DOI: 10.1007/s11010-008-9811-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

Review 1.  Wnt genes.

Authors:  R Nusse; H E Varmus
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

2.  Synthetic phosphopeptides are substrates for casein kinase II.

Authors:  D W Litchfield; A Arendt; F J Lozeman; E G Krebs; P A Hargrave; K Palczewski
Journal:  FEBS Lett       Date:  1990-02-12       Impact factor: 4.124

3.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes.

Authors:  S L Mansour; K R Thomas; M R Capecchi
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

4.  Biosynthesis of casein kinase II in lymphoid cell lines.

Authors:  B Lüscher; D W Litchfield
Journal:  Eur J Biochem       Date:  1994-03-01

5.  The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain.

Authors:  A P McMahon; A Bradley
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

6.  Wnt-3a regulates somite and tailbud formation in the mouse embryo.

Authors:  S Takada; K L Stark; M J Shea; G Vassileva; J A McMahon; A P McMahon
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

7.  The midbrain-hindbrain phenotype of Wnt-1-/Wnt-1- mice results from stepwise deletion of engrailed-expressing cells by 9.5 days postcoitum.

Authors:  A P McMahon; A L Joyner; A Bradley; J A McMahon
Journal:  Cell       Date:  1992-05-15       Impact factor: 41.582

8.  In-situ hybridization of tropoelastin mRNA during the development of the multilayered neonatal rat aortic smooth muscle cell culture.

Authors:  P Toselli; B Faris; D Sassoon; B A Jackson; C Franzblau
Journal:  Matrix       Date:  1992-08

9.  Beta-catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation.

Authors:  Markus Morkel; Joerg Huelsken; Maki Wakamiya; Jixiang Ding; Marc van de Wetering; Hans Clevers; Makoto M Taketo; Richard R Behringer; Michael M Shen; Walter Birchmeier
Journal:  Development       Date:  2003-12       Impact factor: 6.868

10.  Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse.

Authors:  Stefan Liebner; Anna Cattelino; Radiosa Gallini; Noemi Rudini; Monica Iurlaro; Stefano Piccolo; Elisabetta Dejana
Journal:  J Cell Biol       Date:  2004-08-02       Impact factor: 10.539

View more
  38 in total

Review 1.  Emergence of protein kinase CK2 as a key target in cancer therapy.

Authors:  Janeen H Trembley; Zhong Chen; Gretchen Unger; Joel Slaton; Betsy T Kren; Carter Van Waes; Khalil Ahmed
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

2.  Comparative phosphoproteomic analysis of neonatal and adult murine brain.

Authors:  Tapasree Goswami; Xue Li; Aidan M Smith; Eva M Luderowski; James J Vincent; John Rush; Bryan A Ballif
Journal:  Proteomics       Date:  2012-07       Impact factor: 3.984

3.  Okur-Chung neurodevelopmental syndrome-linked CK2α variants have reduced kinase activity.

Authors:  I Dominguez; J M Cruz-Gamero; V Corasolla; N Dacher; S Rangasamy; A Urbani; V Narayanan; H Rebholz
Journal:  Hum Genet       Date:  2021-05-04       Impact factor: 4.132

4.  Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells.

Authors:  Janeen H Trembley; Gretchen M Unger; Vicci L Korman; Diane K Tobolt; Zygmunt Kazimierczuk; Lorenzo A Pinna; Betsy T Kren; Khalil Ahmed
Journal:  Cancer Lett       Date:  2011-10-12       Impact factor: 8.679

5.  Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation.

Authors:  Janeen H Trembley; Gretchen M Unger; Omar Cespedes Gomez; J Abedin; Vicci L Korman; Rachel I Vogel; Gloria Niehans; Betsy T Kren; Khalil Ahmed
Journal:  Mol Cell Pharmacol       Date:  2014

6.  Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.

Authors:  Janeen H Trembley; Gretchen M Unger; Diane K Tobolt; Vicci L Korman; Guixia Wang; Kashif A Ahmad; Joel W Slaton; Betsy T Kren; Khalil Ahmed
Journal:  Mol Cell Biochem       Date:  2011-07-15       Impact factor: 3.396

7.  CK2α is essential for embryonic morphogenesis.

Authors:  Isabel Dominguez; Irene R Degano; Kathleen Chea; Julie Cha; Paul Toselli; David C Seldin
Journal:  Mol Cell Biochem       Date:  2011-07-15       Impact factor: 3.396

8.  Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes.

Authors:  Esther Landesman-Bollag; Anna Belkina; Beth Hovey; Edward Connors; Charles Cox; David C Seldin
Journal:  Mol Cell Biochem       Date:  2011-07-19       Impact factor: 3.396

9.  Inhibition of protein kinase CK2 expression and activity blocks tumor cell growth.

Authors:  Dan Zhu; Jennifer Hensel; Robert Hilgraf; Mahan Abbasian; Owen Pornillos; Gordafaried Deyanat-Yazdi; Xuequn Helen Hua; Sarah Cox
Journal:  Mol Cell Biochem       Date:  2009-07-21       Impact factor: 3.396

Review 10.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.